Miscarriage patients have fewer treatment options in states with abortion bans, study shows
A study published in the Journal of the American Medical Association found that pregnant patients experiencing miscarriage in states with abortion bans have fewer treatment options, including a shift away from the recommended two-drug regimen (mifepristone and misoprostol) to less effective methods. The study also noted increased use of expectant management, which carries higher risks of complications.
Mentioned
Journal of the American Medical AssociationorganizationOregon Health and Science UniversityorganizationmifepristonetopicmisoprostoltopicAmerican College of Obstetricians and GynecologistsorganizationU.S. Food and Drug AdministrationorganizationAlabamaplaceArkansasplaceGeorgiaplaceIdahoplaceKentuckyplaceLouisianaplaceMississippiplaceMissouriplaceNorth DakotaplaceOklahomaplaceSouth DakotaplaceTennesseeplaceTexasplaceWest Virginiaplace